TAMPA, Fla., Aug. 4, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, today announced its fall conference schedule. Executive and scientific leadership will present at key global biopharma and neuroscience events to share advances in the PSIL-006 clinical program.
Read more at prnewswire.comPsilera Announces Fall Conference Schedule to Showcase Next-Generation Psychedelic and Neuroplastogen Pipeline
Barchart·08/04/2026 07:15:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.